Le Lézard
Classified in: Science and technology
Subject: CALENDAR OF EVENTS

Hamilton Thorne to Announce Q4 and Year-End 2017 Financial Results and Hold Conference Call on April 25, 2018


BEVERLY, Mass. and TORONTO, April 18, 2018 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX-V:HTL), a leading world-wide provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART) and developmental biology research markets, today announced that it will release its financial results for the three months and year ended December 31, 2017 before market open on Wednesday, April 25, 2018. The press release, with accompanying financial information, will be posted on the Company's website at www.hamiltonthorne.com and on www.sedar.com.

The Company will follow with a conference call on the same day, at 11:00 a.m. EDT to review highlights of results. All interested parties are welcome to join the conference call by dialing toll free 1-855-223-7309 in North America, or 647-788-4929 from other locations, and requesting Conference ID 3284638. A recording of the call will be available on Hamilton Thorne's website shortly after the call.

About Hamilton Thorne Ltd. (www.hamiltonthorne.com)

Hamilton Thorne is a leading global provider of precision instruments, consumables, software and services that reduce cost, increase productivity, improve results and enable breakthroughs in Assisted Reproductive Technologies (ART) and developmental biology research markets. Hamilton Thorne markets its products and services under the Hamilton Thorne, Gynemed and Embryotech Laboratories brands, through its growing sales force and distributors worldwide. Hamilton Thorne's customer base consists of fertility clinics, university research centers, animal breeding facilities, pharmaceutical companies, biotechnology companies, and other commercial and academic research establishments.

Neither the Toronto Venture Exchange, nor its regulation services provider (as that term is defined in the policies of the exchange), accepts responsibility for the adequacy or accuracy of this release.

For more information, please contact:

David Wolf, President & CEO                            Michael Bruns, CFO
Hamilton Thorne Ltd.                                         Hamilton Thorne Ltd.
978-921-2050                                                     978-921-2050
[email protected]                                      [email protected]


These press releases may also interest you

at 17:45
Tiger Aesthetics Medical, LLC today announced its acquisition of substantially all of the assets associated with the Sientra Inc. breast implant business. This strategic acquisition will complement Tiger Aesthetics' upcoming adipose cell and tissue...

at 17:43
Radiance Technologies (Radiance) is pleased to announce the promotion of Ms. Jamie N. Jones to Chief Administrative Officer (CAO). As CAO, Ms. Jones will strategize internal and external communications, build community engagement, and build...

at 17:41
NOT FOR DISTRIBUTION TO UNITED STATES WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. Q4/2023 revenues of US$12.7 million, adjusted EBITDA1 of US$2.1 million and gross profit margin of 61%.  Renewal rate of 90% for top customers in 2023.Annual...

at 17:38
Nuvo, the fastest trade credit management platform for B2B sellers, has announced a strategic relationship with Equifax®, a leading global data, analytics and technology company....

at 17:35
Pivotree Inc. ("Pivotree" or the "Company"), a leading provider of frictionless commerce solutions, will release first quarter 2024 financial results on Friday, May 10, 2024 before the market opens. The webinar will be hosted by Bill Di Nardo, CEO,...

at 17:31
DelveInsight's Stargardt Disease Market Insights report includes a comprehensive understanding...



News published on and distributed by: